D&D Pharmatech Co., Ltd. · KRX:347850

D&D Pharmatech Co., Ltd. financial statements

D&D Pharmatech Co., Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue4.30B11.4B18.7B610.6M1.36B
Gross profit4.30B11.4B18.7B610.6M1.36B
Research and development25.1B23.3B20.0B47.1B56.8B
Selling, general and administrative2.39B7.53B7.95B9.46B2.35B
Operating income-34.0B-34.2B-8.90B-188.4B-75.7B
Depreciation and amortization5.53B2.23B1.26B2.76B11.9B
EBITDA-28.5B-32.0B-7.64B-185.6B-63.8B
Interest expense470.6M614.8M1.43B2.96B1.01B
Income before tax-24.9B-30.4B4.49B-163.5B-72.0B
Net income-23.6B-28.6B3.93B-136.1B-68.2B
Earnings per share, basic-541.04-2,708.40377.19-13,046.65-1,635.41

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents32.9B30.0B15.6B25.5B76.0B
Short-term investments200
Receivables3.04B72.6M124.7M11.2M
Current assets51.0B39.8B19.6B33.4B81.7B
Property, plant and equipment7.73B6.42B3.02B
Goodwill2.04B2.09B9.90B9.74B34.8B
Total assets97.5B97.5B79.2B93.6B251.1B
Current liabilities5.42B11.1B7.49B54.9B66.9B
Long-term debt000
Total liabilities18.6B27.4B32.6B84.2B112.8B
Shareholders' equity79.5B70.1B46.6B9.44B132.1B
Shares outstanding43.5M10.6M10.4M10.4M41.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations-21.1B-21.8B-9.12B-53.1B-51.9B
Capital spending-64.4M-415.8M-45.2M-718.9M-2.22B
Free cash flow-21.2B-22.2B-9.16B-53.8B-54.2B
Cash from investing-539.5M268.1M-478.9M
Cash from financing36.3B-629.9M1.99B
Share buybacks38.0B147.0M
Change in cash2.87B14.4B-9.86B-50.5B15.3B